Ask AI about Pentraxin Therapeutics
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Español
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Pentraxin Therapeutics
Pentraxin Therapeutics Ltd is a University College London spin out company founded in 2001 by Professor Sir Mark Pepys FRS. In September 2011 Sir Mark retired as head of medicine at the Royal Free Campus of UCL and became the first Director of the new UCL Wolfson Drug Discovery Unit, which he created with funding from the Wolfson Foundation. Since 2012 the core funding of the Unit has been provided by the NIHR via its UCL/UCLH Biomedical Research Centre. Pentraxin holds the intellectual property and proprietary knowledge created by Sir Mark and his research group.
- Website
- pentraxin.wordpress.com
- [email protected]
